Drug-Approval, page 9

Search results for Drug-Approval

Found 1718 articles. Showing from 81 to 90.

Drugs (2013-04-23)
Ospemifene: first global approval.

The oncologist (2012-12-20)
Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration.

Clinical and experimental rheumatology (2012-12-14)
Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.

Clinical cancer research (2013-04-22)
U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma.

Clinical pharmacology and therapeutics (2011-08-24)
Analysis of labeling decisions regarding therapeutic indications during new drug application reviews in Japan.

The Annals of thoracic surgery (2010-07-08)
Endovascular repair of descending thoracic aneurysms: results with "on-label" application in the post Food and Drug Administration approval era.

European journal of clinical pharmacology (2008-03-19)
Predictors of orphan drug approval in the European Union.

Nature reviews. Drug discovery (2012-10-12)
Vemurafenib: the first drug approved for BRAF-mutant cancer.

The Journal of bone and joint surgery. American volume (2011-04-21)
Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: res

Critical reviews in oncology/hematology (2013-02-19)
Approval probabilities and regulatory review patterns for anticancer drugs in the European Union.

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013